NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Pharmaceutical company Mallinckrodt said Friday it has agreed to buy three hemostasis products, used in surgery to stop bleeding, from The Medicines Co. for $175 million. The products — RECOTHROM Thrombin topical, PreveLeak and RAPLIXA (a fibrin sealant), are bing acquired by subsidiaries of Mallinckrodt from The Medicines Co.’s global…

news

AstraZeneca PLC on Thursday said it would buy a 55% stake in biotech company Acerta Pharma for $4 billion, in the U.K. drugmaker’s latest effort to rebuild its pipeline. AstraZeneca said it would pay an initial $2.5 billion for the stake, then a further unconditional $1.5 billion on receipt of…

news

Drug executive Martin Shkreli stood defiantly against a swell of outrage this fall over his decision to jack up prices for lifesaving drugs. But, according to federal prosecutors, his financial foundation was crumbling. On Thursday, agents from the Federal Bureau of Investigation arrested the 32-year-old Mr. Shkreli at his Manhattan…

news

Harbin Gloria Pharmaceuticals Co Ltd says to acquire 15 percent stake in Shanxi Pude Pharma for 386.7 million yuan ($59.66 million).   reuters.com

news

China's drug regulator said on Thursday it will strengthen oversight of clinical trials of new drugs, where it said regulation was falling short despite a recent push to improve the quality of local drugs and compete better with international rivals. The China Food and Drug Administration has rejected dozens of…

news

Drugmaker Valeant Pharmaceuticals International Inc on Wednesday said that fourth-quarter profit was hit when it cut ties with pharmacy Philidor Rx Services, but that it could contain the damage next year and grow profit. The company said it would rebuild lost business through a distribution agreement with Walgreens pharmacies announced…

news

Pharmaceuticals giant Novartis is pinning its hopes on a 43-year-old Harvard cancer research star to help fill gaps in its immuno-oncology arsenal after "missing the boat" on some promising therapies. James "Jay" Bradner, from Harvard's Dana-Farber Cancer Institute, will head Novartis Institutes for Biomedical Research starting on March 1. He…

news

Shanghai Fosun Pharmaceutical Group Co Ltd says unit plans to invest 400 million yuan ($61.80 million) in hospital operator in Qingdao city.   reuters.com

news

Drug developer Advaxis Inc said on Wednesday the U.S. Food and Drug Administration had lifted a clinical hold on three of its experimental cancer therapies, sending the company's shares up as much as 38 percent. The U.S. health regulator had in October put on hold mid-stage trials of the company's…

news

Valeant Pharmaceuticals International Inc. said Tuesday it has found a new partner to replace the controversial mail-order pharmacy that had helped patients fill prescriptions for the company’s pricey skin and other drugs. Walgreens Boots Alliance Inc., which runs the largest chain of pharmacies in the U.S., will sell Valeant’s signature…